174 related articles for article (PubMed ID: 34576133)
1. Personalised Medicine for Colorectal Cancer Using Mechanism-Based Machine Learning Models.
Nwaokorie A; Fey D
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576133
[TBL] [Abstract][Full Text] [Related]
2. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
3. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.
Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB
Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456
[TBL] [Abstract][Full Text] [Related]
4. Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.
Hossain MJ; Chowdhury UN; Islam MB; Uddin S; Ahmed MB; Quinn JMW; Moni MA
Comput Biol Med; 2021 Aug; 135():104539. PubMed ID: 34153790
[TBL] [Abstract][Full Text] [Related]
5. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
[No Abstract] [Full Text] [Related]
8. LDB1 overexpression is a negative prognostic factor in colorectal cancer.
García SA; Swiersy A; Radhakrishnan P; Branchi V; Kanth Nanduri L; Győrffy B; Betzler AM; Bork U; Kahlert C; Reißfelder C; Rahbari NN; Weitz J; Schölch S
Oncotarget; 2016 Dec; 7(51):84258-84270. PubMed ID: 27713177
[TBL] [Abstract][Full Text] [Related]
9. ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.
Blaj C; Bringmann A; Schmidt EM; Urbischek M; Lamprecht S; Fröhlich T; Arnold GJ; Krebs S; Blum H; Hermeking H; Jung A; Kirchner T; Horst D
Clin Cancer Res; 2017 Jun; 23(11):2769-2780. PubMed ID: 27903678
[No Abstract] [Full Text] [Related]
10. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
11. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
12. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
Sun S; Wang Y; Wang J; Bi J
J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
[TBL] [Abstract][Full Text] [Related]
13. Annexin A9 promotes cell proliferation by regulating the Wnt signaling pathway in colorectal cancer.
Lu X; Hu L; Mao J; Zhang S; Cai Y; Chen W
Hum Cell; 2023 Sep; 36(5):1729-1740. PubMed ID: 37349657
[TBL] [Abstract][Full Text] [Related]
14. Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
Makondi PT; Chu CM; Wei PL; Chang YJ
PLoS One; 2017; 12(7):e0180616. PubMed ID: 28749961
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0005075 predicts a poor prognosis and acts as an oncogene in colorectal cancer via activating Wnt/β-catenin pathway.
Jin YD; Ren YR; Gao YX; Zhang L; Ding Z
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3311-3319. PubMed ID: 31081084
[TBL] [Abstract][Full Text] [Related]
16. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
17. Gene dysregulation analysis builds a mechanistic signature for prognosis and therapeutic benefit in colorectal cancer.
Li Q; Dai W; Liu J; Sang Q; Li YX; Li YY
J Mol Cell Biol; 2020 Jul; 12(11):881-893. PubMed ID: 32717065
[TBL] [Abstract][Full Text] [Related]
18. A Systems Biology Approach to Understand the Racial Disparities in Colorectal Cancer.
Nwaokorie A; Kolch W; Fey D
Cancer Res Commun; 2024 Jan; 4(1):103-117. PubMed ID: 38051091
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
